Stryker Corporation

NYSE:SYK

Medical - Devices

Healthcare
$318.15 +3.08%

+$9.29 today

Market cap
$121.12B
Beta
0.79
P/E (TTM)
35.6
EPS (TTM)
$8.72
Dividend yield
1.11%
52W Low $281.00High $404.87

Volume 3.25M

Average 2.49M

SYK Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Stryker CorporationNYSE: SYK

Total Equity · Q2 FY2026 · quarter ended Jun 2026

Total equity rises 13.2% from a year ago

Total equity stood at $23.99B at the end of Q2 FY2026, up 13.2% from a year earlier and up 4.4% from the prior quarter. Over 3 fiscal years it compounded at +10.5% a year.

Context

  • Total equity amounted to 50.0% of total assets at the end of Q2 FY2026, up 4.3 pp from a year earlier.
  • Total equity increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps rising in the next quarterly balance sheet after a +13.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$23.99B+4.4% QoQ
Last fiscal yearDec 2025
$22.42B+8.7% YoY
Year agoJun 2025
$21.19B+13.2% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.2%——
1 year+8.7%——
3-year CAGR+10.5%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
22.42B USD
Year-over-year change
+8.7%
4-year CAGR
+10.8%

Total Equity vs competitors

How SYK compares with its peers on the latest reported figures

  • SYK's Jun 2026 total equity of $23.99B is the 2nd highest of the 11 companies compared; the peer median is $1.26B.
  • Its year-over-year change of +13.2% is the 2nd highest of 11, against a peer median of +2.4%.
  • Total equity amounts to 50.0% of total assets for SYK, versus a peer median of 49.8%.
SYK Competitors Peer median
Total Equity for SYK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MDTMedtronic plcJul 2026$50.85B +5.6%-1.0%54.5%
SYKStryker CorporationJun 2026$23.99B +13.2%+10.5%50.0%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$12.63B +0.8%+1.8%55.4%
SNNSmith & Nephew plcDec 2025$5.29B +0.5%+0.2%50.6%
GMEDGlobus Medical, Inc.Jun 2026$4.77B +11.0%+35.3%86.9%
ENOVEnovis CorporationApr 2026$1.48B -43.5%-24.4%38.6%
IARTIntegra LifeSciences Holdings CorporationMar 2026$1.04B -31.6%-16.7%29.1%
CNMDCONMED CorporationMar 2026$1.02B +4.1%+11.5%44.0%
OFIXOrthofix Medical Inc.Mar 2026$435.19M -5.0%+10.1%49.1%
XTNTXtant Medical Holdings, Inc.Mar 2026$48.6M +10.8%+14.2%62.3%
ATECAlphatec Holdings, Inc.Mar 2026$18.26M +129.3%—2.3%
Peer median (excluding SYK) $1.26B+2.4%+1.8%49.8%

Competitors are the stored peer set for SYK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.94B1.84B2.97B3.65B4.01B
Short-term Investments75M84M82M841M89M
Net Receivables3.02B3.57B3.77B3.99B4.04B
Inventory3.31B4B4.84B4.77B5.31B
Other Current Assets662M787M857M1.59B1.31B
Total Current Assets10.02B10.28B12.52B14.85B14.76B
Property, Plant & Equipment (Net)3.25B3.44B3.71B3.96B4.4B
Goodwill12.92B14.88B15.24B15.86B19.29B
Intangible Assets4.84B4.89B4.59B4.4B5.68B
Long-term Investments66M90M2M39M2M
Tax Assets1.76B1.41B1.67B1.74B1.1B
Other Non-current Assets1.78B1.9B2.18B2.13B2.62B
Total Non-current Assets24.61B26.61B27.39B28.12B33.09B
Total Assets34.63B36.88B39.91B42.97B47.84B
Account Payables1.13B1.41B1.52B1.68B1.8B
Short-term Debt119M1.31B2.24B1.55B1.15B
Tax Payables192M292M391M539M0
Deferred Revenue00000
Other Current Liabilities2.02B2.14B2.3B2.44B2.49B
Total Current Liabilities4.55B6.3B7.92B7.62B7.79B
Long-term Debt12.47B11.86B10.9B12.19B14.86B
Deferred Tax Liabilities68M67M63M82M137M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.36B1.68B2.08B2.07B2.29B
Total Non-current Liabilities15.21B13.97B13.4B14.72B17.63B
Total Liabilities19.75B20.27B21.32B22.34B25.42B
Common Stock38M38M38M38M38M
Retained Earnings13.48B14.77B16.77B18.53B20.47B
Accumulated OCI(531M)(221M)(416M)(293M)(687M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity14.88B16.62B18.59B20.63B22.42B
Total Debt12.9B13.53B13.49B14.12B16.36B
Net Debt9.96B11.68B10.52B10.47B12.35B

Stryker Corporation

NYSE:SYK

Intrinsic Alpha fair value

Locked

Current Price

$318.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.